Exploring the Futureof Psychedelics
Psychedelic Science 2025
The world’s largest psychedelic gathering returns to Denver on June 16-20, 2025.
Learn more about presenting and other ways to participate at Psychedelic Science.
Experience the Most Extraordinary Week of the Psychedelic Movement.
.png)
Join over 12,000 attendees for a weeklong journey filled with education, community, and inspiration.
Classes & Workshops
Dive deep into the world of psychedelic science, facilitated by experts in the fields of medicine, healthcare, policy, and culture.
Deep Space
Enjoy an immersive creative environment featuring dozens of art installations and activities.
10+ Educational Stages
Gain insights and knowledge from hundreds of educational sessions featuring presenters from across the world.
Expo Hall
Discover your community in a city block-sized showcase of hundreds of psychedelic organizations, businesses, and projects.
Innovative Speakers
Hundreds of leaders exploring the full spectrum of psychedelics across 14 programming tracks.
14 Programming Tracks
Big ideas and high-profile speakers exploring the integration of psychedelics into broader society and culture.
A half-day series on ways plant medicine can support Black communities in healing from systemic and interpersonal racism, trauma, and exploitation.
The infrastructure for scaling safe and responsible access to psychedelics, including finance, drug development, regulatory, clinics and service centers, technology, and community institutions.
Dialogues and stories about psychedelics from the perspectives of unique and intersectional communities.
The latest insights on the neuroscience, pharmacology, and chemistry of psychedelics, and the quest to understand their mechanisms of action.
A single-day forum focused on the new systems of state-regulated access to psychedelic experiences in Colorado and Oregon.
A single-day forum for veterans, first responders, and their families about the growing movement to bring psychedelic healing to their communities.
Personal selections from MAPS Founder Rick Doblin, focusing on the living legacy and pioneers of psychedelic research, therapy, and culture.
The world of ethnobotanical practices that use psychedelic plant medicines, including Indigenous, traditional, spiritual, and contemporary approaches.
The legislative, judicial, and regulatory foundations required to create and manage safe and responsible access to psychedelics and a post-prohibition society.
The intersection of psychedelics and society, including popular culture, the arts and music, media, religion and spirituality, ethnicity and culture, and the psychedelic community itself.
New research spanning a variety of fields, including clinical trials, naturalistic use, risk & safety, public opinion, health and wellness, religion & spirituality, and global culture.
Findings and updates from clinical trials studying the potential of psychedelics in the treatment of serious mental illness and neurological disorders.
Deep discussions for clinicians and facilitators from intake to integration, including critical viewpoints on evidence-based practices, education and training, ethics and accountability, and the delivery of care.
.png)
Pilar
Guzmán
Editorial Director, Oprah Daily
.png)
Tim
Ryan
Former United States Congressman, Ohio; President & CEO, Celtic Consulting
.png)
Bessel
Van der Kolk
Trauma Expert; Author of #1 NYT Bestseller “The Body Keeps the Score”
Kyrsten
Sinema
Former United States Senator, Arizona
Paul
Stamets
Earthling; Author; Mycologist; Founder, MycoMedica & Fungi Perfecti
Rick
Doblin
Founder & President, Multidisciplinary Association for Psychedelic Studies (MAPS)
Robin
Carhart-Harris
Neuroscience & Psychopharmacology Researcher, Carhart-Harris Lab at UCSF
.png)
Monica
Williams
Clinical Psychologist; Professor & Research Chair, University of Ottawa
Amy
Emerson
Former CEO of Lykos Therapeutics
Doug
Drysdale
CEO, Cybin
.png)
Taylor
West
Executive Director, Healing Advocacy Fund
.png)
Chris
Stauffer
Marcela
Ot'alora
Co-founder, Memoru Center for Visionary Healing Arts; Former Principal Investigator for Lykos MDMA-assisted therapy research
.png)
David
Nutt
.png)
Amber
Capone
Co-founder and CEO, Veterans Exploring Treatment Solutions (VETS)
.png)
Diego
Ugalde
Get InvolvedIn PS2025
Presenter, community partner, creative, volunteer, and scholarship opportunities are now open.
Sponsor + Exhibitor Opportunities
.jpg)
Connect with the largest audience in psychedelics as a sponsor or exhibitor at Psychedelic Science 2025.
Fill out our sales lead form to receive a prospectus and talk to our sales team. Get in touch soon to enjoy early pricing.
Have Questions?
We're Here to Help.
We are just getting started and will be announcing more information in the weeks and months to come.
In the meantime, visit our FAQ area to learn more about answers to common questions, including event features, customer support, presentation and participation proposals, and press and media inquiries.
If you don’t see what you’re looking for in the FAQ area, you can always contact us.
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
